# FDA Inspection 820185 - Atlanta Blood Services - February 28, 2013

Source: https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/9ea8beb8-28db-4f78-97df-e109f0d5b0cf
Source feed: FDA_Inspections

> FDA Inspection 820185 for Atlanta Blood Services on February 28, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 820185
- Company Name: Atlanta Blood Services
- Inspection Date: 2013-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1193134 - 2022-11-11](https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/51be179d-ae06-43b0-aad1-7ca2f6f17557)
- [FDA Inspection 1193134 - 2022-11-11](https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/5ff85983-7dbe-49ed-83e3-45855bc5acad)
- [FDA Inspection 1079952 - 2019-02-06](https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/0af3025b-5d9b-4f5e-9547-e8af7bcb133e)
- [FDA Inspection 1079952 - 2019-02-06](https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/bf2720c9-4826-40eb-a6a6-9cf8e1a3b539)
- [FDA Inspection 946036 - 2015-10-15](https://www.keypedia.com/records/fda_inspections/atlanta-blood-services/eba3b482-faaf-48da-9122-8cb562f49c57)

Company: https://www.keypedia.com/companies/atlanta-blood-services/6bf559e8-57b5-4007-be23-a4b904af50b7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d